In addition, Murn et al. reported that PTGER4 knockdown accelerated tumor growth, whereas PTGER4 overexpression yielded significant protection to B cell lymphoma development through the intrinsic activity between PTGER4 and PGE2–EP4 signaling target genes. This evidence concerns the gene PTGER4 and B-cell non-Hodgkin lymphoma.